These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
7. [Mastocytosis: when should it be considered?]. Comte-Perret S; Bart PA; Spertini F; Leimgruber A Rev Med Suisse; 2009 Apr; 5(199):837-42. PubMed ID: 19441750 [TBL] [Abstract][Full Text] [Related]
8. [Systemic mastocytosis. A review of current diagnostic and therapeutic approaches]. Pari F; Zamagni MD; Carnevali C; Pagani M; Rabbi C; Cantore M; Cavazzini G; Aitini E; Smerieri F Recenti Prog Med; 1999 Mar; 90(3):169-72. PubMed ID: 10228358 [TBL] [Abstract][Full Text] [Related]
10. [Urticaria pigmentosa: a current approach]. Pérez-Elizondo AD; Zepeda-Ortega B; del Pino-Rojas GT Rev Alerg Mex; 2009; 56(4):124-35. PubMed ID: 19768974 [TBL] [Abstract][Full Text] [Related]
11. The presence of mast cell clonality in patients with unexplained anaphylaxis. Gülen T; Hägglund H; Sander B; Dahlén B; Nilsson G Clin Exp Allergy; 2014 Sep; 44(9):1179-87. PubMed ID: 25039926 [TBL] [Abstract][Full Text] [Related]
12. [Therapeutically relevant mutations in the receptor tyrosine kinase KIT in mastocytosis]. Sotlar K Verh Dtsch Ges Pathol; 2007; 91():169-76. PubMed ID: 18314612 [TBL] [Abstract][Full Text] [Related]
13. Biology, classification and treatment of human mastocytosis. Valent P Wien Klin Wochenschr; 1996; 108(13):385-97. PubMed ID: 8766423 [TBL] [Abstract][Full Text] [Related]
14. Mastocytosis: the puzzling clinical spectrum and challenging diagnostic aspects of an enigmatic disease. Gülen T; Hägglund H; Dahlén B; Nilsson G J Intern Med; 2016 Mar; 279(3):211-28. PubMed ID: 26347286 [TBL] [Abstract][Full Text] [Related]
15. Current approaches to the diagnosis and treatment of systemic mastocytosis. Bains SN; Hsieh FH Ann Allergy Asthma Immunol; 2010 Jan; 104(1):1-10; quiz 10-2, 41. PubMed ID: 20143640 [TBL] [Abstract][Full Text] [Related]
16. Mastocytosis: current concepts in diagnosis and treatment. Escribano L; Akin C; Castells M; Orfao A; Metcalfe DD Ann Hematol; 2002 Dec; 81(12):677-90. PubMed ID: 12483363 [TBL] [Abstract][Full Text] [Related]
17. Immunophenotypic characterization of bone marrow mast cells in mastocytosis and other mast cell disorders. Sánchez-Muñoz L; Teodósio C; Morgado JM; Escribano L Methods Cell Biol; 2011; 103():333-59. PubMed ID: 21722810 [TBL] [Abstract][Full Text] [Related]
18. [Guidelines for the diagnosis, treatment and management of mastocytosis]. De la Hoz B; González de Olano D; Alvarez I; Sánchez L; Núñez R; Sánchez I; Escribano L An Sist Sanit Navar; 2008; 31(1):11-32. PubMed ID: 18496577 [TBL] [Abstract][Full Text] [Related]
19. Venom immunotherapy in patients with mastocytosis and hymenoptera venom anaphylaxis. González-de-Olano D; Alvarez-Twose I; Vega A; Orfao A; Escribano L Immunotherapy; 2011 May; 3(5):637-51. PubMed ID: 21554093 [TBL] [Abstract][Full Text] [Related]
20. Current state of biology and diagnosis of clonal mast cell diseases in adults. Alvarez-Twose I; Morgado JM; Sánchez-Muñoz L; García-Montero A; Mollejo M; Orfao A; Escribano L Int J Lab Hematol; 2012 Oct; 34(5):445-60. PubMed ID: 22551157 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]